Sequoia Financial Advisors’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-7,406
| Closed | -$495K | – | 1378 |
|
|
2024
Q3 | $495K | Sell |
7,406
-1,316
| -15% | -$88K | 0.01% | 747 |
|
|
2024
Q2 | $1.04M | Buy |
8,722
+575
| +7% | +$68.3K | 0.01% | 471 |
|
|
2024
Q1 | $868K | Buy |
8,147
+923
| +13% | +$98.4K | 0.01% | 507 |
|
|
2023
Q4 | $718K | Buy |
7,224
+2,474
| +52% | +$246K | 0.01% | 629 |
|
|
2023
Q3 | $491K | Buy |
4,750
+218
| +5% | +$22.5K | 0.01% | 529 |
|
|
2023
Q2 | $551K | Buy |
4,532
+65
| +1% | +$7.9K | 0.01% | 499 |
|
|
2023
Q1 | $686K | Sell |
4,467
-191
| -4% | -$29.3K | 0.02% | 387 |
|
|
2022
Q4 | $837K | Buy |
4,658
+1,902
| +69% | +$342K | 0.02% | 329 |
|
|
2022
Q3 | $326K | Sell |
2,756
-406
| -13% | -$48K | 0.01% | 370 |
|
|
2022
Q2 | $452K | Buy |
3,162
+12
| +0.4% | +$1.72K | 0.01% | 343 |
|
|
2022
Q1 | $543K | Buy |
3,150
+523
| +20% | +$90.2K | 0.01% | 341 |
|
|
2021
Q4 | $667K | Buy |
+2,627
| New | +$667K | 0.02% | 282 |
|
|
2021
Q3 | – | Sell |
-1,112
| Closed | -$261K | – | 381 |
|
|
2021
Q2 | $261K | Buy |
+1,112
| New | +$261K | 0.01% | 404 |
|